David P. Schenkein, Chief Executive Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 91,252 shares at $90.07 ($8.2M) on 2018-05-30, disclosed to the SEC on 2018-06-01.
Open-market sale of $8.2M AGIO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.07 | 45,626 | $4.1M | 50.0% |
| 2 | $90.07 | 45,626 | $4.1M | 50.0% |
| Total | $90.07 avg | 91,252 | $8.2M | 100% |
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |